Thus, recombinant tissue plasminogen activator (TPA) has been used for the treatment of this problem; however, this product has caused a worsening of the lesions as a result of the cerebral ischemia, contributing to the increase in the infarct size, cerebral edema, and hemorrhage intracranial [70]. The gene discussed is PLAT; the disease is Cerebral ischemia.